Sana Biotechnology (NASDAQ:SANA – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a ...

Fintel reports that on March 18, 2025, Citizens Capital Markets upgraded their outlook for Sana Biotechnology (NasdaqGS:SANA) ...

Jefferies analyst Roger Song initiated coverage of Sana Biotechnology (SANA) with a Buy rating and $7 price target Sana is a clinical stage ...

Tea for Sana is a story-driven exploration game set in the mountains of a Slavic-inspired fantasy world. Discover recipes, forage for ingredients, and cook traditional dishes to restore the ...

Luanda - Biologists play a crucial role in finding innovative solutions for the conservation of ecosystems and the responsible use of natural resources, said the President of the Order of Biologists, ...

Pre-earnings options volume in Sana Biotechnology (SANA) is 2.0x normal with calls leading puts 150:1. Implied volatility suggests the market is anticipating a move near 6.3%, or 16c, after ...

Last month, Sana Bio announced positive initial results from a potentially groundbreaking T1D study of its experimental cell therapy, UP421. Notably, in the investigator-sponsored, first-in-human ...

Last month, Sana Bio announced positive initial results from a potentially groundbreaking T1D study of its experimental cell therapy, UP421. Notably, in the investigator-sponsored, first-in-human ...

SEATTLE, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will ...